Changes in expression of immunohistochemical biomarkers after neoadjuvant chemotherapy in gastric cancer

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2000041098

Enrollment

Unknown

Registered

2020-12-17

Start date

2020-12-17

Completion date

Unknown

Last updated

2021-03-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

gastric cancer

Interventions

case series:Nil

Eligibility

Sex/Gender

All

Age

18 Years to 90 Years

Inclusion criteria

Inclusion criteria: Patients diagnosed as locally advanced gastric cancer (AJCC stage II-III) via imaging and pathological examination; all patients were pathologically diagnosed and had complete clinical data.

Exclusion criteria

Exclusion criteria: Patients whose pathology was not adenocarcinoma; patients who didn't undergo radical surgery.

Design outcomes

Primary

Measure	Time frame
Combined Positive Score;tumor regression grade;	—

Secondary

Measure	Time frame
microsatellite stable state;	—

Countries

China

Contacts

Public ContactJia-FU Ji

Peking University Cancer Hospital & Institute

15201278036@139.com+86 10-88196970

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026